Repro Med Systems Inc (REPR)

[hfmanager]

Nice to meet you @blue_skies. The company was dropped on my desk by one of our equity research analysts. We have been conducting a significant amount of research (which includes gauging public sentiment about the company) to determine the investment potential and risk. Some initial points that come to mind:

* A troubled past and uncertain future, potentially an interest for activist investors
* Growth prospects but little pipeline development to substantiate and support that growth (we’d like to see substantial R&D investments for a company in this industry)
* BS and IS look fine, however, legal expenses were significant this past quarter
* We’ve been monitoring stock intraday action closely
* Our team has spotted some intraday trading anomalies in the Level 2 and Level 3
* We are working with forensic analysts to determine what this signifies
* We want to better understand the public sentiment about this stock
* We need to comprehend the outlook and plan in greater detail
* We would definitely expect and need to see additional information in quarterly releases regarding “partnerships”, pipeline, etc.
* The management’s plan lacks specificity that would allow for firms in AM, IB, or CM to make more informed investment decisions
* The company seems to meet some, but not all uplist requirements. We will have to see what exchange they are interested in

The next quarter report will be an opportunity to more accurately judge the firm’s prospects.